HARMONY BIOSCIENCES HOLDINGS, INC. Earnings Per Share (Diluted)
HARMONY BIOSCIENCES HOLDINGS, INC. (HRMY) reported Earnings Per Share (Diluted) of $1.28 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareDiluted · last filed 2026-08-04
- HARMONY BIOSCIENCES HOLDINGS, INC. earnings per share, diluted for the quarter ending 2026-06-30 was $1.28, a 88.24% increase year-over-year.
- HARMONY BIOSCIENCES HOLDINGS, INC. earnings per share, diluted for the quarter ending 2026-03-31 was $0.55, a 29.49% decline year-over-year.
- HARMONY BIOSCIENCES HOLDINGS, INC. earnings per share, diluted for the quarter ending 2025-12-31 was $0.39, a 54.35% decline year-over-year.
- HARMONY BIOSCIENCES HOLDINGS, INC. earnings per share, diluted for the quarter ending 2025-09-30 was $0.87, a 10.13% increase year-over-year.
- HARMONY BIOSCIENCES HOLDINGS, INC. earnings per share, diluted for fiscal 2025 was $2.71, a 7.97% increase from fiscal 2024.
- HARMONY BIOSCIENCES HOLDINGS, INC. earnings per share, diluted for fiscal 2024 was $2.51, a 17.84% increase from fiscal 2023.
- HARMONY BIOSCIENCES HOLDINGS, INC. earnings per share, diluted for fiscal 2023 was $2.13, a 28.28% decline from fiscal 2022.
- HARMONY BIOSCIENCES HOLDINGS, INC. earnings per share, diluted for fiscal 2022 was $2.97, a 412.07% increase from fiscal 2021.
| Period end | Earnings Per Share, Diluted 3 month | Earnings Per Share, Diluted 6 month | Earnings Per Share, Diluted 9 month | Earnings Per Share, Diluted 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.28 10-Q · filed 2026-08-04 | $1.84 10-Q · filed 2026-08-04 | $2.23 derived: net income ÷ weighted average shares · filed 2026-08-04 | $3.10 derived: net income ÷ weighted average shares · filed 2026-08-04 |
| 2026-03-31 | $0.55 10-Q · filed 2026-05-07 | $0.94 derived: net income ÷ weighted average shares · filed 2026-05-07 | $1.81 derived: net income ÷ weighted average shares · filed 2026-05-07 | $2.49 derived: net income ÷ weighted average shares · filed 2026-08-04 |
| 2025-12-31 | $0.39 derived: net income ÷ weighted average shares · filed 2026-02-24 | $1.26 derived: net income ÷ weighted average shares · filed 2026-02-24 | $1.94 derived: net income ÷ weighted average shares · filed 2026-08-04 | $2.71 10-K · filed 2026-02-24 |
| 2025-09-30 | $0.87 10-Q · filed 2025-11-04 | $1.55 derived: net income ÷ weighted average shares · filed 2026-08-04 | $2.32 10-Q · filed 2025-11-04 | $3.18 derived: net income ÷ weighted average shares · filed 2026-08-04 |
| 2025-06-30 | $0.68 10-Q · filed 2026-08-04 | $1.46 10-Q · filed 2026-08-04 | $2.31 derived: net income ÷ weighted average shares · filed 2026-08-04 | $3.10 derived: net income ÷ weighted average shares · filed 2026-08-04 |
| 2025-03-31 | $0.78 10-Q · filed 2026-05-07 | $1.63 derived: net income ÷ weighted average shares · filed 2026-05-07 | $2.42 derived: net income ÷ weighted average shares · filed 2026-05-07 | $2.63 derived: net income ÷ weighted average shares · filed 2026-05-07 |
| 2024-12-31 | $0.85 derived: net income ÷ weighted average shares · filed 2026-02-24 | $1.64 derived: net income ÷ weighted average shares · filed 2026-02-24 | $1.85 derived: net income ÷ weighted average shares · filed 2026-02-24 | $2.51 10-K · filed 2026-02-24 |
| 2024-09-30 | $0.79 10-Q · filed 2025-11-04 | $1.00 derived: net income ÷ weighted average shares · filed 2025-11-04 | $1.66 10-Q · filed 2025-11-04 | $2.11 derived: net income ÷ weighted average shares · filed 2026-02-24 |
| 2024-06-30 | $0.20 10-Q · filed 2025-08-05 | $0.87 10-Q · filed 2025-08-05 | $1.32 derived: net income ÷ weighted average shares · filed 2026-02-24 | $1.96 derived: net income ÷ weighted average shares · filed 2026-02-24 |
| 2024-03-31 | $0.67 10-Q · filed 2025-05-06 | $1.12 derived: net income ÷ weighted average shares · filed 2026-02-24 | $1.75 derived: net income ÷ weighted average shares · filed 2026-02-24 | $2.32 derived: net income ÷ weighted average shares · filed 2026-02-24 |
| 2023-12-31 | $0.45 derived: net income ÷ weighted average shares · filed 2026-02-24 | $1.09 derived: net income ÷ weighted average shares · filed 2026-02-24 | $1.65 derived: net income ÷ weighted average shares · filed 2026-02-24 | $2.13 10-K · filed 2026-02-24 |
| 2023-09-30 | $0.63 10-Q · filed 2024-10-29 | $1.20 derived: net income ÷ weighted average shares · filed 2024-10-29 | $1.68 10-Q · filed 2024-10-29 | $2.47 derived: net income ÷ weighted average shares · filed 2025-02-25 |
| 2023-06-30 | $0.56 10-Q · filed 2024-08-06 | $1.05 10-Q · filed 2024-08-06 | $1.83 derived: net income ÷ weighted average shares · filed 2025-02-25 | $3.27 derived: net income ÷ weighted average shares · filed 2025-02-25 |
| 2023-03-31 | $0.48 10-Q · filed 2024-04-30 | $1.27 derived: net income ÷ weighted average shares · filed 2025-02-25 | $2.70 derived: net income ÷ weighted average shares · filed 2025-02-25 | $3.09 derived: net income ÷ weighted average shares · filed 2025-02-25 |
| 2022-12-31 | $0.79 derived: net income ÷ weighted average shares · filed 2025-02-25 | $2.22 derived: net income ÷ weighted average shares · filed 2025-02-25 | $2.61 derived: net income ÷ weighted average shares · filed 2025-02-25 | $2.97 10-K · filed 2025-02-25 |
| 2022-09-30 | $1.44 10-Q · filed 2023-10-31 | $1.83 derived: net income ÷ weighted average shares · filed 2023-10-31 | $2.18 10-Q · filed 2023-10-31 | $2.56 derived: net income ÷ weighted average shares · filed 2024-02-22 |
| 2022-06-30 | $0.39 10-Q · filed 2023-08-01 | $0.74 10-Q · filed 2023-08-01 | $1.12 derived: net income ÷ weighted average shares · filed 2024-02-22 | $0.97 derived: net income ÷ weighted average shares · filed 2024-02-22 |
| 2022-03-31 | $0.35 10-Q · filed 2023-05-02 | $0.73 derived: net income ÷ weighted average shares · filed 2024-02-22 | $0.58 derived: net income ÷ weighted average shares · filed 2024-02-22 | $0.82 derived: net income ÷ weighted average shares · filed 2024-02-22 |
| 2021-12-31 | $0.38 derived: net income ÷ weighted average shares · filed 2024-02-22 | $0.22 derived: net income ÷ weighted average shares · filed 2024-02-22 | $0.46 derived: net income ÷ weighted average shares · filed 2024-02-22 | $0.58 10-K · filed 2024-02-22 |
| 2021-09-30 | -$0.17 10-Q · filed 2022-11-01 | $0.08 derived: net income ÷ weighted average shares · filed 2022-11-01 | $0.20 10-Q · filed 2022-11-01 | $0.20 derived: net income ÷ weighted average shares · filed 2023-02-21 |
| 2021-06-30 | $0.24 10-Q · filed 2022-08-02 | $0.37 10-Q · filed 2022-08-02 | $0.37 derived: net income ÷ weighted average shares · filed 2023-02-21 | $0.45 derived: net income ÷ weighted average shares · filed 2023-02-21 |
| 2021-03-31 | $0.13 10-Q · filed 2022-05-03 | $0.12 derived: net income ÷ weighted average shares · filed 2023-02-21 | $0.19 derived: net income ÷ weighted average shares · filed 2023-02-21 | $0.24 derived: net income ÷ weighted average shares · filed 2023-02-21 |
| 2020-12-31 | -$0.00 derived: net income ÷ weighted average shares · filed 2023-02-21 | $0.04 derived: net income ÷ weighted average shares · filed 2023-02-21 | $0.05 derived: net income ÷ weighted average shares · filed 2023-02-21 | -$2.48 10-K · filed 2023-02-21 |
| 2020-09-30 | -$0.14 10-Q · filed 2021-11-09 | $0.10 derived: net income ÷ weighted average shares · filed 2021-11-09 | -$4.15 10-Q · filed 2021-11-09 | -$5.46 derived: net income ÷ weighted average shares · filed 2022-02-28 |
| 2020-06-30 | -$1.34 10-Q · filed 2021-08-10 | -$7.63 10-Q · filed 2021-08-10 | -$9.64 derived: net income ÷ weighted average shares · filed 2022-02-28 | -$13.74 derived: net income ÷ weighted average shares · filed 2022-02-28 |
| 2020-03-31 | -$6.30 10-Q · filed 2021-05-11 | -$9.64 derived: net income ÷ weighted average shares · filed 2022-02-28 | -$13.74 derived: net income ÷ weighted average shares · filed 2022-02-28 | |
| 2019-12-31 | -$4.68 derived: net income ÷ weighted average shares · filed 2022-02-28 | -$8.79 derived: net income ÷ weighted average shares · filed 2022-02-28 | -$24.07 10-K · filed 2022-02-28 | |
| 2019-09-30 | -$5.26 10-Q · filed 2020-11-12 | -$18.15 10-Q · filed 2020-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 |